# NHS Framework Agreement for Glatiramer acetate injection - North of England

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Generics \[UK\] ta Mylan
- Award value: £0
- Tender value: £10,432,586
- Award date: 29 August 2018
- Published: 1 October 2018
- Contract start: 1 September 2018
- Contract end: 29 February 2020
- Stage: awarded
- Procurement category: goods
- Notice ID: 1700f2ee-4201-43e9-9e5c-41a3e928faee-243479
- OCID: ocds-b5fd17-ed6126f2-1b57-433b-a8db-a858839857f8

## Description

NHS Framework Agreement for the supply of Glatiramer Acetate Injection to the North of England region\. Offer reference number: CM/PHR/18/5565 Period of framework agreement: 1 September 2018 - 29 February 2020 with an option to extend at the Authority's discretion for up to 24 months

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [NHS Framework Agreement for South of England Branded - Tranche B and Annual](/contracts/ocds-b5fd17-4c9013e7-bbb5-4254-b8ad-705ccb4e5887): NHS England
- [NHS National Generic Pharmaceuticals - Clozapine](/contracts/ocds-b5fd17-1a206321-9cf2-47a6-98e6-fcc05ff101ee): NHS England
- [NHS National Pharmaceuticals Transition 2021\_2 - Pemetrexed LSNE](/contracts/ocds-b5fd17-50f66811-fc34-4a5c-a6ba-6d48c9386892): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/1700f2ee-4201-43e9-9e5c-41a3e928faee-243479)